Effects of Fish Oil and Physical Activity on Fatigue in Patients With Advanced Cancer Receiving Regorafenib
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Fish oil (Primary) ; Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2017 Planned End Date changed from 1 Apr 2022 to 1 Mar 2022.
- 16 Mar 2017 Planned primary completion date changed from 1 Apr 2022 to 1 Mar 2022.